Gilead Sciences, Inc.
PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS

Last updated:

Abstract:

The present disclosure relates to methods and intermediates for the synthesis of certain compounds that inhibit MCL1, for use in the treatment of cancers.

Status:
Application
Type:

Utility

Filling date:

17 Nov 2021

Issue date:

9 Jun 2022